title: Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
abstract: Severe side effects of chemotherapy in pediatric patients with acute lymphoblastic leukemia are rare, but well-known. We present two pediatric patients who developed ascending motoric paraplegia (AMP) following intrathecal chemotherapy. Both patients suffered from progressive weakness of their lower extremities, neurogenic bladder dysfunction, autonomous neural dysregulation and minor sensory deficits. Despite an initially similar clinical picture, progression and outcome were fairly different. There is convincing evidence that AMP is caused by spinal cord toxicity of intrathecally applied toxic agents such as cytarabin and/or methotrexate leading to spinal demyelinisation as demonstrated by elevated myelin basic protein in cerebrospinal fluid.
authors.affiliation: University Children's Hospital, Technical University of Dresden, Germany. nina.rolf@uniklinikum-dresden.de
authors.forename: N
authors.initials: N
authors.lastname: Rolf
authors.forename: H
authors.initials: H
authors.lastname: Boehm
authors.forename: A M
authors.initials: AM
authors.lastname: Kaindl
authors.forename: I
authors.initials: I
authors.lastname: Lauterbach
authors.forename: M
authors.initials: M
authors.lastname: Suttorp
mesh_terms: D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D018450:Disease Progression; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007278:Injections, Spinal / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010264:Paraplegia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine; D008727:Methotrexate